Approval for the addition of the micro-driver rapid exchange delivery platformand the addition of the medtronic mexico facility in tijuana for the manufacturing of cathetersub-assemblies. the device, as modified, will be marketed under the trade name micro-driverrapid exchange (rx) coronary stent system and is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease due to discrete de novo lesions with reference vessel diameters of 2.25 - 2.75 mm and <= 21 mm in length. outcome beyond 270 days for this permanent implant is unknown at present.